Prot# M16-135: A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Project: Research project

StatusActive
Effective start/end date9/8/179/7/20

Funding

  • AbbVie Inc. (Prot# M16-135)